Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Ramalingam

Showing results (251-260 of 502) with videos related to

Pageof 51
Sort By:
The Journal of Biological Chemistry|March 29, 2013
Protein phosphatase 2A and DNA-dependent protein kinase are involved in mediating rapamycin-induced Akt phosphorylationYikun Li, Xuerong Wang, Ping Yue, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 23, 2015
Bevacizumab in Combination with Taxane versus Non-Taxane Containing Regimens for Advanced/Metastatic Nonsquamous Non-Small-Cell Lung Cancer: A Systematic ReviewMadhusmita Behera, Rathi N Pillai, Taofeek K Owonikoko, et al.
Lung Cancer (Amsterdam, Netherlands)|February 9, 2025
Comprehensive molecular profiling of squamous non-small cell lung cancer reveals high incidence of actionable genomic alterations among patients with no history of smokingJoshua E Reuss, Jacob Zaemes, Nishant Gandhi, et al.
Oral Oncology|July 26, 2014
Concurrent therapy with taxane versus non-taxane containing regimens in locally advanced squamous cell carcinomas of the head and neck (SCCHN): a systematic reviewMadhusmita Behera, Taofeek K Owonikoko, Sungjin Kim, et al.
Cancer|March 26, 2014
Long-term use of valproic acid in US veterans is associated with a reduced risk of smoking-related cases of head and neck cancerHyunseok Kang, Theresa W Gillespie, Michael Goodman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 2008
Outcomes for elderly, advanced-stage non small-cell lung cancer patients treated with bevacizumab in combination with carboplatin and paclitaxel: analysis of Eastern Cooperative Oncology Group Trial 4599Suresh S Ramalingam, Suzanne E Dahlberg, Corey J Langer, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 12, 2016
International Experts Panel Meeting of the Italian Association of Thoracic Oncology on Antiangiogenetic Drugs for Non-Small Cell Lung Cancer: Realities and HopesFilippo de Marinis, Emilio Bria, Fortunato Ciardiello, et al.
Cancer|July 26, 2017
HER2 mutations in lung adenocarcinomas: A report from the Lung Cancer Mutation ConsortiumRathi N Pillai, Madhusmita Behera, Lynne D Berry, et al.
Targeted Oncology|January 18, 2023
Osimertinib for EGFR-Mutant Non-Small-Cell Lung Cancer Central Nervous System Metastases: Current Evidence and Future Perspectives on Therapeutic StrategiesSanjay Popat, Myung-Ju Ahn, Simon Ekman, et al.
Clinical Pharmacology and Therapeutics|November 27, 2023
Longitudinal Circulating Tumor DNA Modeling to Predict Disease Progression in First-Line Mutant Epidermal Growth Factor Receptor Non-Small Cell Lung CancerMartin Johnson, Carlos Serra Traynor, Karthick Vishwanathan, et al.
Pageof 51

Showing results (251-260 of 502) with videos related to

Sort By:
Pageof 51
The Journal of Biological Chemistry|March 29, 2013
Protein phosphatase 2A and DNA-dependent protein kinase are involved in mediating rapamycin-induced Akt phosphorylationYikun Li, Xuerong Wang, Ping Yue, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 23, 2015
Bevacizumab in Combination with Taxane versus Non-Taxane Containing Regimens for Advanced/Metastatic Nonsquamous Non-Small-Cell Lung Cancer: A Systematic ReviewMadhusmita Behera, Rathi N Pillai, Taofeek K Owonikoko, et al.
Lung Cancer (Amsterdam, Netherlands)|February 9, 2025
Comprehensive molecular profiling of squamous non-small cell lung cancer reveals high incidence of actionable genomic alterations among patients with no history of smokingJoshua E Reuss, Jacob Zaemes, Nishant Gandhi, et al.
Oral Oncology|July 26, 2014
Concurrent therapy with taxane versus non-taxane containing regimens in locally advanced squamous cell carcinomas of the head and neck (SCCHN): a systematic reviewMadhusmita Behera, Taofeek K Owonikoko, Sungjin Kim, et al.
Cancer|March 26, 2014
Long-term use of valproic acid in US veterans is associated with a reduced risk of smoking-related cases of head and neck cancerHyunseok Kang, Theresa W Gillespie, Michael Goodman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 2008
Outcomes for elderly, advanced-stage non small-cell lung cancer patients treated with bevacizumab in combination with carboplatin and paclitaxel: analysis of Eastern Cooperative Oncology Group Trial 4599Suresh S Ramalingam, Suzanne E Dahlberg, Corey J Langer, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 12, 2016
International Experts Panel Meeting of the Italian Association of Thoracic Oncology on Antiangiogenetic Drugs for Non-Small Cell Lung Cancer: Realities and HopesFilippo de Marinis, Emilio Bria, Fortunato Ciardiello, et al.
Cancer|July 26, 2017
HER2 mutations in lung adenocarcinomas: A report from the Lung Cancer Mutation ConsortiumRathi N Pillai, Madhusmita Behera, Lynne D Berry, et al.
Targeted Oncology|January 18, 2023
Osimertinib for EGFR-Mutant Non-Small-Cell Lung Cancer Central Nervous System Metastases: Current Evidence and Future Perspectives on Therapeutic StrategiesSanjay Popat, Myung-Ju Ahn, Simon Ekman, et al.
Clinical Pharmacology and Therapeutics|November 27, 2023
Longitudinal Circulating Tumor DNA Modeling to Predict Disease Progression in First-Line Mutant Epidermal Growth Factor Receptor Non-Small Cell Lung CancerMartin Johnson, Carlos Serra Traynor, Karthick Vishwanathan, et al.
Pageof 51